Healthcare
Live Price
Offline$44.38
+1.84% today
1Y Change
+35.01%
Window
Jun 20, 2025 → Jun 17, 2026
Coverage: 249 bars · Jun 20, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Supernus Pharmaceuticals, Inc. (SUPN) is a Healthcare stock with a market cap of $2.76B and listed on NASDAQ. The stock last traded around $44.38 and up 35.0% across the available one-year price window (Jun 20, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +8.6%, EPS growth of -150.7%, a dividend yield of 0.0%. What stands out right now is revenue +8.6%, EPS -150.7%, free cash flow -73.1% with operating margin -6.2% and ROIC -3.1%. Valuation is more restrained than many high-expectation growth names at price/sales 3.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SUPN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SUPN
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SUPN Max Drawdown
-23.54%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SUPN and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.